CRON
Cronos Group Inc
NASDAQ: CRON · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.58
-2.64% today
Updated 2026-04-29
Market cap
$1.02B
P/E ratio
—
P/S ratio
6.93x
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$2 – $3
Volume
1.5M
Cronos Group Inc (CRON) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-119290.00 | $-1.43M | $-992645.00 | $-4.82M | $-4.41M | $-7.15M | $-130.01M | $-144.87M | $-153.62M | $-88.95M | $-42.84M | $18.84M | $26.32M |
| Capital expenditures | $0.00 | $959550.00 | $1.09M | $1.13M | $33.96M | $84.26M | $38.95M | $35.39M | $12.26M | $5.03M | $3.42M | $13.15M | $26.17M |
| Depreciation | — | $28108.00 | $81661.00 | $284760.00 | $792047.00 | $1.84M | $3.91M | $7.04M | $15.40M | $13.12M | $8.11M | $9.34M | — |
| Stock-based comp | — | $724376.00 | $-1.92M | $228269.00 | $1.48M | $3.11M | $11.62M | $15.36M | $10.15M | $15.12M | $8.77M | $8.70M | $7.05M |
| Free cash flow | $-119290.00 | $-2.39M | $-2.08M | $-5.95M | $-38.37M | $-91.41M | $-168.96M | $-180.26M | $-165.88M | $-93.98M | $-46.26M | $5.69M | $151611.00 |
| Investing cash flow | $-1.41M | $-6.34M | $-1.05M | $-5.96M | $-30.83M | $-89.19M | $-603.54M | $20.15M | $-28.90M | $-1.84M | $-59.50M | $175.15M | — |
| Financing cash flow | $1.53M | $8.45M | $2.28M | $16.82M | $39.81M | $113.54M | $1.86B | $-3.05M | $-13.44M | $-2.90M | $-1.03M | $-1.23M | — |
| Dividends paid | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $65.10M | $2.61M | — | $384000.00 | $345000.00 | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.12B | $-127.77M | $-195.96M | — | — | — | — |